Is Buying Insulet Corporation (PODD) Here a Winning Strategy?

March 14, 2018 - By Marie Mckinney

Investors sentiment decreased to 1.1 in 2017 Q3. Its down 0.10, from 1.2 in 2017Q2. It is negative, as 14 investors sold Insulet Corporation shares while 55 reduced holdings. 31 funds opened positions while 45 raised stakes. 60.96 million shares or 0.49% less from 61.26 million shares in 2017Q2 were reported.
Putnam Investments Ltd Company invested 0% of its portfolio in Insulet Corporation (NASDAQ:PODD). Wellington Management Gru Ltd Liability Partnership holds 6.46M shares or 0.08% of its portfolio. Natixis has invested 0.02% of its portfolio in Insulet Corporation (NASDAQ:PODD). The New York-based Goldman Sachs Group Inc has invested 0% in Insulet Corporation (NASDAQ:PODD). 211,020 are owned by Ubs Asset Mgmt Americas Incorporated. State Street has 1.17M shares. Point72 Asset Lp owns 605,900 shares for 0.15% of their portfolio. Eam Invsts reported 0.29% of its portfolio in Insulet Corporation (NASDAQ:PODD). Sg Americas Lc accumulated 9,247 shares or 0% of the stock. Driehaus Cap Limited Liability Company accumulated 79,990 shares. Koch Inc reported 5,725 shares. 3,800 were accumulated by Arrowstreet Capital Partnership. Deutsche Savings Bank Ag has 182,074 shares for 0.01% of their portfolio. Contravisory Invest Management reported 15 shares. Solutions Ltd Liability Corp stated it has 0% in Insulet Corporation (NASDAQ:PODD).

Since March 6, 2018, it had 0 buys, and 2 insider sales for $150,547 activity. The insider Lemoine David A sold $49,235.

The stock of Insulet Corporation (NASDAQ:PODD) reached all time high today, Mar, 14 and still has $89.95 target or 7.00 % above today’s $84.07 share price. This indicates more upside for the $4.91 billion company. This technical setup was reported by If the $89.95 PT is reached, the company will be worth $343.63 million more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

The stock decreased 0.79% or $0.67 during the last trading session, reaching $84.07. About 464,552 shares traded. Insulet Corporation (NASDAQ:PODD) has risen 48.83% since March 14, 2017 and is uptrending. It has outperformed by 32.13% the S&P500.

Analysts await Insulet Corporation (NASDAQ:PODD) to report earnings on May, 14. They expect $-0.19 earnings per share, down 11.76 % or $0.02 from last year’s $-0.17 per share. After $-0.12 actual earnings per share reported by Insulet Corporation for the previous quarter, Wall Street now forecasts 58.33 % negative EPS growth.

Insulet Corporation (NASDAQ:PODD) Ratings Coverage

Among 19 analysts covering Insulet Corporation (NASDAQ:PODD), 13 have Buy rating, 1 Sell and 5 Hold. Therefore 68% are positive. Insulet Corporation had 54 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was initiated by Morgan Stanley on Monday, November 2 with “Equal-Weight”. The firm has “Hold” rating given on Monday, September 25 by Canaccord Genuity. The rating was downgraded by BTIG Research to “Hold” on Monday, July 17. Canaccord Genuity upgraded Insulet Corporation (NASDAQ:PODD) on Friday, November 3 to “Buy” rating. Jefferies maintained it with “Buy” rating and $45 target in Thursday, August 4 report. Piper Jaffray maintained Insulet Corporation (NASDAQ:PODD) on Thursday, October 5 with “Buy” rating. The firm has “Buy” rating given on Monday, January 8 by Leerink Swann. Northland Capital maintained Insulet Corporation (NASDAQ:PODD) rating on Friday, November 6. Northland Capital has “Outperform” rating and $40 target. Robert W. Baird upgraded it to “Outperform” rating and $47 target in Friday, January 6 report. Stephens maintained the shares of PODD in report on Thursday, February 22 with “Equal-Weight” rating.

More important recent Insulet Corporation (NASDAQ:PODD) news were published by: which released: “Insulet Corporation’s (PODD) CEO Patrick Sullivan on Q4 2017 Results …” on February 22, 2018, also published article titled: “Insulet Has Strong Presence at the International ATTD Congress; Presents …”, published: “Insulet Corporation (PODD) PT Raised to $90 at Cowen; Beat and Raise” on February 22, 2018. More interesting news about Insulet Corporation (NASDAQ:PODD) was released by: and their article: “Insulet Q4 Earnings Preview” with publication date: February 21, 2018.

Insulet Corporation, a medical device company, develops, makes, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company has market cap of $4.91 billion. The firm offers Omnipod Insulin Management System , which consists of the OmniPod, an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It currently has negative earnings. It also customizes the Omnipod System technology platform for the delivery of subcutaneous drugs across various therapeutic areas.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: